Dear Patients – Allergy Partners has been recently notified that Mylan, the manufacturer of Epi-Pen brand of injectable Epinephrine, has issued a voluntary recall of selected lots of this product. You or your child may have been prescribed EpiPen or EpiPen Jr for the treatment of severe allergic reactions (called anaphylaxis) due to food, bee sting or other allergens. Below is information from the Mylan web site. We encourage you to read this information carefully and follow the recommended steps. Please contact Mylan at the number below for specific information regarding the recall and information for the product exchange
Meridian Medical Technologies, a Pfizer company and Mylan’s manufacturing partner for EpiPen® Auto-Injector, has expanded a voluntary recall of select lots of EpiPen (epinephrine injection, USP) and EpiPen Jr® (epinephrine injection, USP) Auto-Injectors to now include additional lots distributed in the U.S. and other markets in consultation with the U.S. Food and Drug Administration (FDA).
The recall impacts certain lots of the 0.3 mg and 0.15 mg strengths of EpiPen Auto-Injector. None of the recalled lots include the authorized generic for EpiPen Auto-Injector, which is also manufactured by Meridian Medical Technologies.
U.S. Impacted Lots:
For additional information, see the press release.
Product Replacement Instructions: Mylan is committed to replacing recalled devices at no cost and Mylan would like to reassure patients that there will be no additional replacement-related financial burden to them as a result of this recall. Patients, customers and distributors are being notified. We are asking patients to keep their existing product until their replacement product can be secured. Patients may receive either EpiPen Auto-Injector or the authorized generic for EpiPen Auto-Injector at the pharmacy as a replacement based on availability. The authorized generic has the exact same drug formulation, has the exact same operating instructions and is therapeutically equivalent to EpiPen Auto Injector, and may be substituted for EpiPen Auto Injector. It is important that patients continue to carry their current EpiPen Auto-Injector until they receive a replacement device. To return your product please contact Stericycle at 877-650-3494. Please check back here soon for updated and additional information on the product return and replacement process.
Patient and Customer Contact: To return your product please contact Stericycle at 877-650-3494. If you have any additional questions regarding this recall, please contact Mylan Customer Relations at 800-796-9526 or firstname.lastname@example.org.